Organization: Health Canada
Year: 2022
Month: March
Request Number: A-2021-001741
Request Summary: The Screening Acceptance Letter(s) from Health Canada to any and all generic drug manufacturers confirming receipt of any and all Abbreviated New Drug Submissions for levothyroxine sodium which appear on the list of Generic submissions under review.
Disposition: Disclosed in part
Number of pages: 1